Showing results (421-430 of 649) with videos related to

Sort By:
Pageof 65
Hemasphere|July 11, 2022
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in GermanyDaniela Skalt, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Hemasphere|July 11, 2022
Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Hemasphere|February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease ProphylaxisSjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Hemasphere|February 27, 2023
Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic LeukemiaSebastian Faehling, Mariana Coelho, Alessia Floerchinger, et al.
Hemasphere|February 27, 2023
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in SwedenCaroline E Weibull, Tove Wästerlid, Björn Engelbrekt Wahlin, et al.
Hemasphere|March 6, 2023
The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell FunctionWilliam Grey, Samantha Atkinson, Beatrice Rix, et al.
Hemasphere|November 7, 2022
Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018Joe West, Peter Stilwell, Hanhua Liu, et al.
Hemasphere|November 7, 2022
Comprehensive Diagnosis and Management of POEMS SyndromeShirley D'Sa, Jahanzaib Khwaja, Stephen Keddie, et al.
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
Hemasphere|May 10, 2021
Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 TrialClaire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, et al.
Pageof 65